Tañeza, Natividad S.
HRN: 21-11-33 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/05/2022
CEFTRIAXONE 1G (VIAL)
12/05/2022
12/11/2022
IV
2g
OD
CAP MR
Waiting Final Action